← FDA DRUG APPROVALS

FDA ANDA · ANDA090326

LIOTHYRONINE SODIUM

Sponsor: PHARMOBEDIENT

APPLICATION
ANDA090326
TYPE
ANDA
ORIGINAL APPROVAL
2009-07-14
LATEST ACTION
2009-07-14
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

LIOTHYRONINE SODIUMDiscontinued
LIOTHYRONINE SODIUM EQ 0.025MG BASE · TABLET · ORAL
LIOTHYRONINE SODIUMDiscontinued
LIOTHYRONINE SODIUM EQ 0.05MG BASE · TABLET · ORAL
LIOTHYRONINE SODIUMDiscontinued
LIOTHYRONINE SODIUM EQ 0.005MG BASE · TABLET · ORAL

Approval history

2009-07-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →